Download PDF
Facial Plast Surg 2011; 27(6): 523-528
DOI: 10.1055/s-0031-1298785
© Thieme Medical Publishers

Hyaluronic Acid Fillers: History and Overview

Ji-Eon Kim1 , Jonathan M. Sykes1
  • 1Division of Facial Plastic and Reconstructive Surgery, Department of Otolaryngology–Head and Neck Surgery, University of California, Davis, Sacramento, California
Further Information

Publication History

Publication Date:
28 December 2011 (online)

Also available at
    Permissions and Reprints

ABSTRACT

Hyaluronic acid (HA) fillers have many favorable characteristics that make it a popular injectable filler device. Its minimal immunogenicity and relative ease of use has helped HA become the most commonly used injectable filler today. A brief history of injectable fillers, the various injection techniques, and legal ramifications are discussed. A review of the most recent literature compares the efficacy and safety of HA to other injectable filler substances.

KEYWORDS

Hyaluronic acid - fillers - Restylane - Perlane - Juvederm

REFERENCES

  • 1 Neuber F. Fat grafting.  Chir Kongr Verhandl Dtsch Ges Chir. 1893;  22 66
    Google Scholar
  • 2 Gersuny R. Ueber eine subcutyane Prosthese.  Z Heilk. 1900;  30 1-5
    Google Scholar
  • 3 U.S. Department of Health and Human Services. U.S. Food and Drug Administration. Sulfanilamide Disaster. Available at: http://www.fda.gov/AboutFDA/WhatWeDo/History/ProductRegulation/SulfanilamideDisaster/default.htm Last accessed, December 15, 2011
    Google Scholar
  • 4 Matton G, Anseeuw A, De Keyser F. The history of injectable biomaterials and the biology of collagen.  Aesthetic Plast Surg. 1985;  9 133-140
    Google Scholar
  • 5 Paraffingranulome S. Munch Med Wochenschr. 1922;  69 215-220
  • 6 Orentreich D S, Orentreich N. Injectable fluid silicone. In: Roenigk R K, Roenigk Jr H H, eds. Dermatologic Surgery: Principles and Practice. New York: Marcel Dekker; 1989: 1349-1395
    Google Scholar
  • 7 Webster R C, Fuleihan N S, Gaunt J M et al.. Injectable silicone for small augmentations: twenty-year experience in humans.  Am J Cosm Surg. 1984;  1 1-7
    Google Scholar
  • 8 Landman M D, Strahan R W, Ward P H. Chin augmentation with polytef paste injection.  Arch Otolaryngol. 1972;  95 72-75
    Google Scholar
  • 9 Ashinoff R. Overview: soft tissue augmentation.  Clin Plast Surg. 2000;  27 479-487
    Google Scholar
  • 10 U.S. Department of Health and Human Services. U.S. Food and Drug Administration. Approved wrinkle fillers. Available at: http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/CosmeticDevices/WrinkleFillers/ucm227749.htm Last accessed, December 15, 2011
    Google Scholar
  • 11 Krauss M C. Recent advances in soft tissue augmentation.  Semin Cutan Med Surg. 1999;  18 119-128
    Google Scholar
  • 12 Duranti F, Salti G, Bovani B, Calandra M, Rosati M L. Injectable hyaluronic acid gel for soft tissue augmentation. A clinical and histological study.  Dermatol Surg. 1998;  24 1317-1325
    Google Scholar
  • 13 Lowe N J, Maxwell C A, Lowe P, Duick M G, Shah K. Hyaluronic acid skin fillers: adverse reactions and skin testing.  J Am Acad Dermatol. 2001;  45 930-933
    Google Scholar
  • 14 Maas C S. Characteristics of implant materials.  Arch Facial Plast Surg. 2000;  2 67
    Google Scholar
  • 15 Micheels P. Human anti-hyaluronic acid antibodies: is it possible?.  Dermatol Surg. 2001;  27 185-191
    Google Scholar
  • 16 Fernández-Aceñero M J, Zamora E, Borbujo J. Granulomatous foreign body reaction against hyaluronic acid: report of a case after lip augmentation.  Dermatol Surg. 2003;  29 1225-1226
    Google Scholar
  • 17 Vartanian A J, Frankel A S, Rubin M G. Injected hyaluronidase reduces restylane-mediated cutaneous augmentation.  Arch Facial Plast Surg. 2005;  7 231-237
    Google Scholar
  • 18 Rohrich R J, Nguyen A T, Kenkel J M. Lexicon for soft tissue implants.  Dermatol Surg. 2009;  35 (Suppl 2) 1605-1611
    Google Scholar
  • 19 U.S. Department of Health and Human Services. U.S. Food and Drug Administration. Restylane™ injectable gel - P020023. Available at: http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/DeviceApprovalsandClearances/Recently-ApprovedDevices/ucm082242.htm Last accessed, December 15, 2011
    Google Scholar
  • 20 ASPS & ASAPS Advisory . Plast Reconstr Surg. 2006;  118 (Suppl 3) 129-132S
  • 21 Baumann L S, Shamban A T, Lupo M P JUVEDERM vs. ZYPLAST Nasolabial Fold Study Group et al. Comparison of smooth-gel hyaluronic acid dermal fillers with cross-linked bovine collagen: a multicenter, double-masked, randomized, within-subject study.  Dermatol Surg. 2007;  33 (Suppl 2) S128-S135
    Google Scholar
  • 22 Lupo M P, Smith S R, Thomas J A, Murphy D K, Beddingfield III F C. Effectiveness of Juvéderm Ultra Plus dermal filler in the treatment of severe nasolabial folds.  Plast Reconstr Surg. 2008;  121 289-297
    Google Scholar
  • 23 Narins R S, Brandt F, Leyden J, Lorenc Z P, Rubin M, Smith S. A randomized, double-blind, multicenter comparison of the efficacy and tolerability of Restylane versus Zyplast for the correction of nasolabial folds.  Dermatol Surg. 2003;  29 588-595
    Google Scholar
  • 24 Moers-Carpi M M, Vogt S, Santos B M, Planas J, Vallve S R, Howell D J. A multicenter, randomized trial comparing calcium hydroxylapatite to two hyaluronic acids for treatment of nasolabial folds.  Dermatol Surg. 2007;  33 (Suppl 2) S144-S151
    Google Scholar
  • 25 Moers-Carpi M M, Tufet J O. Calcium hydroxylapatite versus nonanimal stabilized hyaluronic acid for the correction of nasolabial folds: a 12-month, multicenter, prospective, randomized, controlled, split-face trial.  Dermatol Surg. 2008;  34 210-215
    Google Scholar
  • 26 Carruthers J, Carruthers A. A prospective, randomized, parallel group study analyzing the effect of BTX-A (Botox) and nonanimal sourced hyaluronic acid (NASHA, Restylane) in combination compared with NASHA (Restylane) alone in severe glabellar rhytides in adult female subjects: treatment of severe glabellar rhytides with a hyaluronic acid derivative compared with the derivative and BTX-A.  Dermatol Surg. 2003;  29 802-809
    Google Scholar
  • 27 Onesti M, Toscani M, Curinga G, Chiummariello S, Scuderi N. Assessment of a new hyaluronic acid filler. Double-blind, randomized, comparative study between Puragen and Captique in the treatment of nasolabial folds.  In Vivo. 2009;  23 479-486
    Google Scholar
  • 28 Kono T, Kinney B M, Groff W F, Chan H H, Ercocen A R, Nozaki M. Randomized, evaluator-blind, split-face comparison study of single cross-linked versus double cross-linked hyaluronic acid in the treatment of glabellar lines.  Dermatol Surg. 2008;  34 (Suppl 1) S25-S30
    Google Scholar
  • 29 Glogau R G, Kane M A. Effect of injection techniques on the rate of local adverse events in patients implanted with nonanimal hyaluronic acid gel dermal fillers.  Dermatol Surg. 2008;  34 (Suppl 1) S105-S109
    Google Scholar
  • 30 DeLorenzi C, Weinberg M, Solish N, Swift A. The long-term efficacy and safety of a subcutaneously injected large-particle stabilized hyaluronic acid-based gel of nonanimal origin in esthetic facial contouring.  Dermatol Surg. 2009;  35 (Suppl 1) 313-321
    Google Scholar
  • 31 Friedman P M, Mafong E A, Kauvar A N, Geronemus R G. Safety data of injectable nonanimal stabilized hyaluronic acid gel for soft tissue augmentation.  Dermatol Surg. 2002;  28 491-494
    Google Scholar
  • 32 Grimes P E, Thomas J A, Murphy D K. Safety and effectiveness of hyaluronic acid fillers in skin of color.  J Cosmet Dermatol. 2009;  8 162-168
    Google Scholar

Jonathan M. SykesM.D. 

Division of Facial Plastic and Reconstructive Surgery, Department of Otolaryngology–Head and Neck Surgery

2521 Stockton Blvd, Suite 6206, Sacramento, CA 95817

Email: jonathan.sykes@ucdmc.ucdavis.edu